<div id="readability-page-1"><p>Shares of Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS - Get Free Report) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $7.40 and traded as low as $7.34. Neuberger Berman High Yield Strategies Fund shares last traded at $7.39, with a volume of 94,239 shares changing hands.</p><h2>Neuberger Berman High Yield Strategies Fund Trading Up 0.7%</h2><p>The company's fifty day moving average is $7.28 and its 200 day moving average is $7.40. </p><h2>Neuberger Berman High Yield Strategies Fund Dividend Announcement</h2><p>The business also recently disclosed a monthly dividend, which will be paid on Friday, January 30th. Stockholders of record on Thursday, January 15th will be paid a dividend of $0.0905 per share. This represents a c) dividend on an annualized basis and a dividend yield of 14.7%. The ex-dividend date of this dividend is Thursday, January 15th. </p><h2>Institutional Investors Weigh In On Neuberger Berman High Yield Strategies Fund</h2><p>Institutional investors have recently bought and sold shares of the stock. Mercer Global Advisors Inc. ADV bought a new position in shares of  Neuberger Berman High Yield Strategies Fund in the third quarter worth approximately $80,000.  Ameriprise Financial Inc. boosted its position in  Neuberger Berman High Yield Strategies Fund by 47.4% during the 3rd quarter. Ameriprise Financial Inc. now owns 117,760 shares of the investment management company's stock valued at $883,000 after buying an additional 37,860 shares during the period.  MRA Advisory Group grew its holdings in  Neuberger Berman High Yield Strategies Fund by 10.9% in the 3rd quarter. MRA Advisory Group now owns 17,261 shares of the investment management company's stock worth $129,000 after acquiring an additional 1,693 shares during the last quarter.  J.W. Cole Advisors Inc. increased its position in shares of  Neuberger Berman High Yield Strategies Fund by 15.2% in the third quarter. J.W. Cole Advisors Inc. now owns 237,490 shares of the investment management company's stock valued at $1,781,000 after acquiring an additional 31,298 shares during the period.  Finally, CoreCap Advisors LLC bought a new position in shares of  Neuberger Berman High Yield Strategies Fund during the third quarter valued at about $94,000. </p><h2>Neuberger Berman High Yield Strategies Fund Company Profile</h2> (Get Free Report)<p>The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.  </p><p>Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Neuberger Berman High Yield Strategies Fund</li><li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li><li>How a Family Trust May Be Able To Help Preserve Your Wealth</li><li>Do not delete, read immediately</li><li>NEW LAW: Congress Approves Setup For Digital Dollar?</li><li>Executive Order 14330: Trump’s Biggest Yet</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Neuberger Berman High Yield Strategies Fund Right Now?</h2><p>Before you consider Neuberger Berman High Yield Strategies Fund, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Neuberger Berman High Yield Strategies Fund wasn't on the list.</p><p>While Neuberger Berman High Yield Strategies Fund currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

USHY

SHYG

NBSD

SPHY

<p>Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) shares fell below their 200-day moving average of $7.40, trading at $7.39 with a volume of 94,239 shares. The fund announced a monthly dividend of $0.0905 per share, payable on January 30th to stockholders of record on January 15th, representing a 14.7% annualized yield. Institutional investors have been active, with notable increases in holdings from firms like Ameriprise Financial and Mercer Global Advisors. The fund focuses on high-yield corporate debt to provide enhanced income.</p>

Market Beat

iShares Broad USD HY Corporate Bd

iShares 0-5 YR HY Corp Bd

Neuberger Berman High Yield Strategies Fund

Neuberger Berman Short Duration Inc ETF

iShares iBoxx  HY Corp Bd

BNY Mellon High Yield Strategies

SPDR Portfolio High Yield Bond ETF

SPDR Bloomberg High Yld  Bd ETF

Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) Shares Cross Below Two Hundred Day Moving Average   - Here's What Happened